Issues and countermeasures for the conduct of phase Ⅰ clinical trial of new drugs
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3760/cma.j.issn.1006-1924.2012.04.004
   		
        
        	
        		- VernacularTitle:实施创新药Ⅰ期临床试验中的问题与对策
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Tianping LI
			        		
			        		;
		        		
		        		
		        		
			        		Yongqing WANG
			        		
			        		;
		        		
		        		
		        		
			        		Hongwen ZHANG
			        		
			        		;
		        		
		        		
		        		
			        		Ning OU
			        		
			        		;
		        		
		        		
		        		
			        		Ningxia LIANG
			        		
			        		;
		        		
		        		
		        		
			        		Hong WANG
			        		
			        		;
		        		
		        		
		        		
			        		Jun ZHAO
			        		
			        		
		        		
		        		
		        		
		        		
		        		
			        		
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Journal Article
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		New drugs;
			        		
			        		
			        		
				        		Phase Ⅰ clinical trials
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Chinese Journal of Medical Science Research Management
	            		
	            		 2012;25(4):229-231
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	Phase Ⅰ Clinical trial of new drugs is key for clinical drug development. In this article,we describe our experience and reflection on phase Ⅰ clinical trials of new drugs at the First Affiliated Hospital of Nanjing Medical University.